SCHEMBL4576117

SCHEMBL4576117

CC(C)=C(O)C(O)C(=O)O

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TP53 P04637 1/20 0.42
TSHR P16473 1/20 0.37
FFAR3 O14843 1/20 0.35
LCK P06239 1/20 0.35
FYN P06241 1/20 0.35
CHRM1 P11229 1/20 0.33
AKR1A1 P14550 1/20 0.33
CHRM3 P20309 1/20 0.33
HTR2A P28223 1/20 0.33
HTR2C P28335 1/20 0.33
ADRA1A P35348 1/20 0.33
HRH1 P35367 1/20 0.33
DRD3 P35462 1/20 0.33
SLC6A3 Q01959 1/20 0.33
HDAC1 Q13547 1/20 0.33
HDAC2 Q92769 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
GRIK1 P39086 1/20 0.31
OR51E2 Q9H255 1/20 0.30
LMNA P02545 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27677436 0.97 TP53 (0.40) TP53TSHRFFAR3LCKFYN
SCHEMBL9730229 0.81 FFAR3 (0.35) TP53TSHRFFAR3LCKFYN
SCHEMBL6053035 0.79
SCHEMBL9732271 0.75 TP53 (0.36) TP53FFAR3LCKFYN
SCHEMBL8829936 0.75 ALDH1A1 (0.32) TP53TSHRFFAR3LCKFYN
SCHEMBL2313654 0.73
SCHEMBL15496658 0.73
SCHEMBL27323652 0.73
SCHEMBL5047864 0.73 TSHR (0.59) TP53TSHRFFAR3LCKFYN
SCHEMBL27675872 0.73 TSHR (0.59) TP53TSHRFFAR3LCKFYN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1778235-A4 QUINAZOLINE DERIVATIVES USEFUL FOR THE TREATMENT OF PERIPHERAL ARTERIAL DISEASE AND AS PHOSPHODIESTERASE INHIBITORS SHIRE HOLDINGS AG (CH) 2008-08-20 EP disclosed
EP-1778235-A2 QUINAZOLINE DERIVATIVES USEFUL FOR THE TREATMENT OF PERIPHERAL ARTERIAL DISEASE AND AS PHOSPHODIESTERASE INHIBITORS Shire Holdings AG (CH) 2007-05-02 EP disclosed
WO-2006017823-A2 QUINAZOLINE DERIVATIVES USEFUL FOR THE TREATMENT OF PERIPHERAL ARTERIAL DISEASE AND AS PHOSPHODIESTERASE INHIBITORS SHIRE HOLDINGS AG (CH) 2006-02-16 WO disclosed
EP-1082323-A2 OXAZOLIDINONE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AstraZeneca UK Limited (GB) 2001-03-14 EP disclosed
WO-1999064417-A2 OXAZOLIDINONE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM ASTRAZENECA AB (SE) 1999-12-16 WO disclosed